カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/29 | 1,226 | 1,242 | 1,226 | 1,229 | +2 | +0.2% | 41,200 |
2021/07/28 | 1,250 | 1,255 | 1,223 | 1,227 | -25 | -2% | 45,800 |
2021/07/27 | 1,240 | 1,259 | 1,239 | 1,252 | +4 | +0.3% | 43,000 |
2021/07/26 | 1,268 | 1,269 | 1,235 | 1,248 | -19 | -1.5% | 129,400 |
2021/07/21 | 1,253 | 1,285 | 1,253 | 1,267 | +5 | +0.4% | 62,400 |
2021/07/20 | 1,245 | 1,264 | 1,222 | 1,262 | +2 | +0.2% | 118,200 |
2021/07/19 | 1,295 | 1,310 | 1,233 | 1,260 | -61 | -4.6% | 251,200 |
2021/07/16 | 1,318 | 1,347 | 1,288 | 1,321 | -11 | -0.8% | 225,200 |
2021/07/15 | 1,406 | 1,439 | 1,329 | 1,332 | -254 | -16% | 578,900 |
2021/07/14 | 1,600 | 1,620 | 1,582 | 1,586 | -23 | -1.4% | 76,100 |
2021/07/13 | 1,628 | 1,652 | 1,606 | 1,609 | -19 | -1.2% | 92,600 |
2021/07/12 | 1,606 | 1,650 | 1,575 | 1,628 | +28 | +1.8% | 224,200 |
2021/07/09 | 1,540 | 1,612 | 1,530 | 1,600 | +36 | +2.3% | 126,800 |
2021/07/08 | 1,673 | 1,730 | 1,557 | 1,564 | -118 | -7% | 542,500 |
2021/07/07 | 1,589 | 1,700 | 1,564 | 1,682 | +93 | +5.9% | 386,500 |
2021/07/06 | 1,550 | 1,625 | 1,508 | 1,589 | +34 | +2.2% | 365,100 |
2021/07/05 | 1,718 | 1,736 | 1,535 | 1,555 | -123 | -7.3% | 1,227,100 |
2021/07/02 | 1,678 | 1,678 | 1,678 | 1,678 | +300 | +21.8% | 66,600 |
2021/07/01 | 1,367 | 1,388 | 1,357 | 1,378 | +11 | +0.8% | 40,200 |
2021/06/30 | 1,357 | 1,367 | 1,355 | 1,367 | +20 | +1.5% | 19,900 |
2021/06/29 | 1,360 | 1,376 | 1,333 | 1,347 | -17 | -1.2% | 53,800 |
2021/06/28 | 1,377 | 1,377 | 1,358 | 1,364 | -16 | -1.2% | 21,400 |
2021/06/25 | 1,385 | 1,385 | 1,366 | 1,380 | +8 | +0.6% | 25,500 |
2021/06/24 | 1,374 | 1,379 | 1,363 | 1,372 | -5 | -0.4% | 25,300 |
2021/06/23 | 1,365 | 1,383 | 1,365 | 1,377 | +12 | +0.9% | 28,700 |
2021/06/22 | 1,353 | 1,376 | 1,341 | 1,365 | +42 | +3.2% | 34,500 |
2021/06/21 | 1,340 | 1,349 | 1,318 | 1,323 | -47 | -3.4% | 45,100 |
2021/06/18 | 1,376 | 1,389 | 1,357 | 1,370 | -13 | -0.9% | 57,500 |
2021/06/17 | 1,335 | 1,383 | 1,323 | 1,383 | +55 | +4.1% | 104,900 |
2021/06/16 | 1,335 | 1,335 | 1,310 | 1,328 | -8 | -0.6% | 37,700 |
2021/06/15 | 1,310 | 1,343 | 1,294 | 1,336 | +53 | +4.1% | 85,500 |
2021/06/14 | 1,263 | 1,288 | 1,261 | 1,283 | +17 | +1.3% | 19,100 |
2021/06/11 | 1,300 | 1,300 | 1,265 | 1,266 | -40 | -3.1% | 64,500 |
2021/06/10 | 1,309 | 1,323 | 1,295 | 1,306 | +2 | +0.2% | 42,500 |
2021/06/09 | 1,274 | 1,305 | 1,274 | 1,304 | +30 | +2.4% | 49,300 |
2021/06/08 | 1,258 | 1,275 | 1,256 | 1,274 | +19 | +1.5% | 31,300 |
2021/06/07 | 1,230 | 1,258 | 1,230 | 1,255 | +28 | +2.3% | 23,000 |
2021/06/04 | 1,233 | 1,238 | 1,222 | 1,227 | -10 | -0.8% | 24,400 |
2021/06/03 | 1,230 | 1,250 | 1,230 | 1,237 | -13 | -1% | 16,900 |
2021/06/02 | 1,245 | 1,256 | 1,230 | 1,250 | -7 | -0.6% | 14,300 |
2021/06/01 | 1,228 | 1,260 | 1,224 | 1,257 | +39 | +3.2% | 40,600 |
2021/05/31 | 1,220 | 1,233 | 1,214 | 1,218 | -27 | -2.2% | 51,700 |
2021/05/28 | 1,250 | 1,250 | 1,228 | 1,245 | -7 | -0.6% | 37,800 |
2021/05/27 | 1,260 | 1,264 | 1,242 | 1,252 | -8 | -0.6% | 16,100 |
2021/05/26 | 1,265 | 1,269 | 1,255 | 1,260 | -4 | -0.3% | 10,500 |
2021/05/25 | 1,230 | 1,268 | 1,230 | 1,264 | +44 | +3.6% | 27,300 |
2021/05/24 | 1,237 | 1,239 | 1,213 | 1,220 | -25 | -2% | 18,100 |
2021/05/21 | 1,236 | 1,252 | 1,236 | 1,245 | +9 | +0.7% | 11,300 |
2021/05/20 | 1,229 | 1,243 | 1,226 | 1,236 | +1 | +0.1% | 12,500 |
2021/05/19 | 1,224 | 1,243 | 1,221 | 1,235 | +5 | +0.4% | 17,700 |
801~
850
件表示中 / 3572件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 30,400円 | -43.1% | - | 0.00% | - | 1.81倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
カイオム | 9,900円 | +2.6% | - | 0.00% | - | 5.73倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
VIS | 91,000円 | +87.8% | +265.7% | 0.00% | 54.65倍 | 2.51倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 82,300円 | +14.5% | - | 0.00% | - | 2.43倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
DELTA-P | 65,800円 | - | - | 0.00% | - | 4.40倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム